Coloplast logo
Coloplast
CLPBY | OTC
Chart Builder DCF Calculator
$7.46
-$0.03 (-0.40%)
At close: Nov 16, 2026, 3:58 PM ET
$7.46
$0.00 (0.00%)
After-hours: Nov 16, 2026, 3:58 PM ET

Coloplast Company Profile

Company profile explained

Company Profile

Coloplast A/S, founded in 1954 and headquartered in Humlebæk, Denmark, operates as a global developer and marketer of intimate healthcare products and services. Its extensive reach spans Denmark, the United States, the United Kingdom, France, and numerous other international regions. The company's activities are organized into three primary segments: Chronic Care, Interventional Urology, and Wound & Skin Care. Within Chronic Care, Coloplast provides advanced ostomy solutions, including the SenSura Mio, recognized for its adaptable fit and discretion, alongside other SenSura offerings and Brava brand accessories. This segment also delivers continence care products such as Conveen Active urine bags, SpeediCath catheters for diverse users, and the Peristeen transanal irrigation system. The Wound & Skin Care division features innovative dressings like the conforming Biatain Silicone and the hydrocolloid Comfeel. Additionally, it offers a broad spectrum of skin care items, encompassing bathing and cleansing products, moisturizers, skin protectants, antifungal treatments, hand cleansers, odor control solutions, and the specialized InterDry system for managing skin folds. Finally, the Interventional Urology segment is dedicated to crafting and commercializing surgical devices that address a range of urological and gynecological conditions, such as urinary stone disease, benign prostatic hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence.

Key Executives

Name Position
Gavin Wood President & Chief Executive Officer
Amanda Rajkumar Executive VP & Chief People Officer
Anders Lonning-Skovgaard Executive Vice President & Chief Financial Officer
Alain Morvan Senior Vice President of Sales Europe
Aleksandra Dimovska Vice President of Investor Relations
Allan Rasmussen Executive Vice President of Global Operations
Caroline Vagner Rosenstand Executive Vice President of Chronic Care Commercial
Dennis Kaysen Vice President of Corporate Communications
Mads Mikkelsen VP of People & Culture - Chronic Care Commercial and Interim Head of Global People & Culture
Nicolai Buhl Andersen Executive Vice President of Chronic Care
Rasmus Hannemann Møller Senior Vice President of Wound & Skin Care
Thomas Barfod Senior Controller & Employees Representative Director
Coloplast
Coloplast logo
Country Denmark
IPO Date Jan 13, 2014
Industry Medical - Instruments & Supplies
Sector Healthcare
Employees 16,907
CEO Gavin Wood

Contact Details

Holtedam 1 Humlebæk, ZE 3050 Denmark

Stock Details

Ticker Symbol CLPBY
Exchange OTC
Fiscal Year October - September
Reporting Currency USD
CIK Code 0001294325
CUSIP Number 19624Y200
ISIN Number US19624Y2000
SIC Code

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.